ASCL1 and glioma: In the future, it will be important to explore the integration of ERK and CDK-mediated ASCL1 phosphoregulation in glioma initiation and maintenance, and to explore whether inhibition of ASCL1 phosphorylation is a rational strategy with which to decrease tumourigenicity by potentiating glioma stem cell differentiation.